NFL Biosciences S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALNFL.PA research report →
About the company
Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S. A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking.
- CEO
- Bruno Lafont
- IPO
- 2021
- Employees
- 4
- HQ
- Castelnau-le-Lez, FR
Price Chart
- Market Cap
- $10.77M
- P/E
- -3.27
- P/S
- 0.00
- P/B
- 35.18
- EV/EBITDA
- -2.48
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -312.05%
- ROIC
- -374.78%
- Revenue
- $0 · -100.00%
- Net Income
- $-3,317,967 · -59.45%
- EPS
- $-0.26 · -23.81%
- Op Income
- $-3,872,629
- FCF YoY
- 0.00%
- 52W High
- $1.85
- 52W Low
- $0.80
- 50D MA
- $0.96
- 200D MA
- $1.11
- Beta
- 1.14
- Avg Volume
- 51.37K
Get TickerSpark's AI analysis on ALNFL.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALNFL.PA coverage
Recent articles, reports, and earnings notes.
No research on ALNFL.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALNFL.PA report →Similar companies
Peers in the same neighborhood.